From left to right: Registered Nurses Polly To and Christine Arde, and Christian Buendia, Patient Care Manager of Surgery at TSH, with the new carbon dioxide laser.
Obstetrician-Gynaecologists at The Scarborough Hospital (TSH) now have access to a new, leading-edge tool to help treat the painful condition endometriosis in women.
TSH Obstetrician-Gynaecologists Dr. Ambika Aneja and Dr. Jing Qin recently completed their first successful minimally invasive surgical procedure for endometriosis using TSH’s new carbon dioxide (CO2) laser.
This vital piece of equipment was purchased with donations to The Scarborough Hospital Foundation.
Using very short pulsed light energy (also known as ultrapulsed), or continuous light beams, the laser precisely removes thin layers of tissue during endometriosis surgery, and helps to treat pain and/or infertility.
“This minimally invasive surgery (MIS) means faster recovery, less pain, and less tissue trauma for our patients,” says Dr. Aneja, who has a specialty in minimally invasive gynaecologic surgery. Reduced tissue trauma also helps to preserve fertility and decrease postoperative scarring.
“The CO2 laser allows us to remove endometriosis more thoroughly, and in a much finer, more precise way so there is less impact on the surrounding normal tissues,” adds Dr. Qin, who also specializes in MIS.
Dr. Qin chose to work at TSH because of her deep desire to serve Scarborough’s diverse population. “The optimization of women’s health is an important matter in communities such as Scarborough, as we work with women to take charge of their health.”
Christian Buendia, Patient Care Manager of Surgery at TSH, points out that “while other academic centres have had this laser for some time, this technology is the first of its kind for a community hospital in the Central East Local Health Integration Network (Central East LHIN).”
“The CO2 laser and the increasing use of MIS is a significant and positive step forward for women’s health services at TSH,” says Obstetrician-Gynaecologist Dr. Nathan Roth, Co-medical Director of the Maternal Newborn and Child Care program at TSH.
“Collaboration, building teams of expertise, and securing leading edge medical equipment is our number one priority and an important part of our strategic thinking and vision. It’s why we come to work,” he adds.
TSH is proud to be a key stakeholder on the Central East LHIN’s Maternal, Neonatal, and Paediatrics Advisory Committee, which has been established with the goal of improving the health of mothers and children up to the age of 18. TSH also provides leadership on the Central East Regional Colposcopy and Cervical Cancer Program.
For more information about the Women’s and Children Health program, visit TSH’s website.